期刊文献+

热毒宁注射液联合阿奇霉素治疗儿童肺炎支原体肺炎的临床疗效 被引量:16

Clinical efficacy of Reduning injection combined with azithromycin in the treatment of mycoplasmal pneumonia of children
下载PDF
导出
摘要 目的探讨热毒宁注射液联合阿奇霉素治疗儿童肺炎支原体肺炎的疗效。方法选取湖北省襄阳市妇幼保健院儿科140例肺炎支原体肺炎患儿,完全随机分为观察组(70例)和对照组(70例)。观察组应用阿奇霉素10mg/(kg·d)加热毒宁注射液10ml静脉滴注,对照组单纯使用阿奇霉素10mg/(kg·d)治疗。2组均治疗5d。治疗5d后观察比较2组临床疗效、退热时间、咳嗽消失时间、平均住院时间的情况。结果观察组总有效率为98.6%(69/70),对照组总有效率为88.6%(62/70),2组比较差异有统计学意义(P〈0.05)。。观察组退热时间、咳嗽消失时间及住院时间均短于对照组[(3.3±1.5)d比(5.0±1.2)d,(4.5±1.2)d比(5.3±1.4)d,(9.8±1.3)d比(12.1±2.0)d],差异均有统计学意义(均P〈0.05)。结论热毒宁联合阿奇霉素治疗小儿肺炎支原体肺炎,症状消失快,疗效明显。 Objective To study the Clinical efficaey of reduning injection combined with azithromycin in the treatment of mycoplaslnal pneumonia of children. Methods Totally 140 children with myeoplasma pneumonia were divided randomly into observation group (70 cases) and control group (70 cases). The observation group was treated with azithromycin combined with reduning injection; the control group was given azithromycinlO rag/( kg · d). Two groups were treated for 5 days. Clinical efficacy, antifebrile time, cough disappeared time and average length of hospital stay of two groups were observed and compared after treatment of 5 days. Results The efficacy rate was 98.6% (69/70) in observation group and 88.6% (62/70) in control group ( P 〈 0.05 ). The antifebrile time, cough disappeared time and average length of hospital stay of observation group were shorter than those of control group [(3.3±1.5)dvs (5.0±1.2)d,(4.5±1.2)d vs (5.3±1.4)d, (9.8±1.3)d vs (12.1 ± 2.0) d ] (all P 〈 0.05 ). Conclusion The combination therapy of reduning injection amt azithromycin (:an improve the symptom of mycoplasmal pneumonia.
出处 《中国医药》 2014年第6期894-896,共3页 China Medicine
关键词 肺炎支原体 热毒宁 阿奇霉素 儿童 Mycoplasmal pneumonia Reduning injection Azithromycin Children
  • 相关文献

参考文献8

二级参考文献30

  • 1辛德莉,李贵,张继红,张小为,王黛,许淑贞,陈湘.聚合酶链反应在肺炎支原体检测中的临床应用与研究[J].中华儿科杂志,1994,32(5):296-297. 被引量:44
  • 2王凤君,赵云,谢尔凡,尤忠义.高效液相色谱法测定生物样品中磷脂含量[J].第三军医大学学报,1996,18(1):67-68. 被引量:18
  • 3刘红菊,陶晓南,辛建宝,熊先智,尚丹.中药热毒宁对急性肺损伤兔肺内致炎因子的影响[J].中国新药与临床杂志,2007,26(6):446-449. 被引量:26
  • 4中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 5Nagalingam NA,Adesiyon AA,Swanaton WH, et al. Prevalence of mycoplasma pneumoniae and chla mydia pneumoniae in pneumo- nia patients in four majou hospital in Trinidad [J]. New Microbi- ol,2004,27(4) :345.
  • 6胡亚美 江载芳.诸福棠实用儿科学(第7版)[M].北京:人民卫生出版社,2002.2171.
  • 7Pereyre S,Guyot C,Renaudin H,et al.In vitro selection and character -rization of resistance to macrolides and related antibiotics in Mycoplasma pnuemoniae. Antimicrob Agents Chemother,2004 ,48:460-465.
  • 8Michelow IC,Olsen K,Lozano J,et al.Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia[ J ].J Clin Microbiol,2004,42(7):3339-41.
  • 9Dorigo-Zetsma JW,Wilbrink B,Van der Nat H,et al.Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoir [J ].J Infect Dis,2001,183 (4):675-8.
  • 10Drummond P,Clark J,Wheeler J,et al.Community acquired pneumonia-a prospective UK study[J].Arch Dis Child,2000,83(5):405-12.

共引文献2041

同被引文献143

  • 1王翠霞,刘程.热毒宁注射液辅助治疗小儿支原体肺炎40例疗效观察[J].医学信息(医学与计算机应用),2014,0(19):76-76. 被引量:1
  • 2抗菌药物临床应用指导原则[J].中国临床药学杂志,2005,14(3). 被引量:82
  • 3李桂芳,李建瑛,左瑞鞠,何洪芹.肺炎支原体感染发病趋势及临床特点[J].实用全科医学,2006,4(6):700-700. 被引量:11
  • 4栾云,刘坤.阿奇霉素治疗小儿肺炎支原体肺炎疗效及安全性观察[J].中国基层医药,2007,14(6):1028-1029. 被引量:10
  • 5胡亚美,江载芳.诸福棠实用儿科学[J].第7版.北京:人民卫生出版社,2002:1634-1678.
  • 6Tang LF,Shi YC,Xu YC,et al.The change of asthma-associated immunological parameters in children with Mycoplasma pneumoniae infection[J].J Asthma,2009,46(3):265-269.
  • 7张昆.探讨中药联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效[J].临床心身疾病杂志,2014,20(14):17-18.
  • 8He XY, Wang XB, Zbang R, et al. Investigation of mycoplas- ma pneumoniae infection in pediatric population from 12 025 cases with respiratory infection [ J ]. Diagn Microbiol Infect Dis,2013,75( 1 ) :22 -27.
  • 9Pitzer VE, Burgner D, Viboud C, et al. Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies [ J ]. Proc Biol Sci, 2012,279(1 739) :2 736 -2 743.
  • 10Jaggi P, Kajon AE, Mejias A, et al. Human adenovirus infec- tion in Kawasaki disease: a confounding bystander? [ J ]. Clin Infect Dis,2013,56(1 ) .58 -64.

引证文献16

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部